Platform
Features
0 followers
GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive.
Industries
Headquarters
Employees
Links
5 members
3 members
Cellphire Therapeutics
3 followers
Entos
1 follower
Watchmaker Genomics
Cue Biopharma
eGenesis
Gilead Sciences
128 followers
Akari Therapeutics
Regeneron
94 followers
Agilent Technologies
63 followers
Alexion Pharmaceuticals
34 followers
GRAIL
27 followers
Explore companies